Clinical trial
Prospective Huntington At Risk Observational Study
NCT00052143 · Huntington Study Group, Other · Completed
Key facts
| NCT number | NCT00052143 |
|---|---|
| Title | Prospective Huntington At Risk Observational Study |
| Official title | Prospective Huntington At Risk Observational Study (PHAROS) |
| Acronym | PHAROS |
| Lead sponsor | Huntington Study Group, Other |
| Collaborators | National Human Genome Research Institute (NHGRI) NIH National Institute of Neurological Disorders and Stroke (NINDS) |
| Status | Completed |
| Study type | Observational |
| Conditions | Huntington Disease |
| Enrollment | 1,001 |
| Start date | Jul 9, 1999 |
| Primary completion | Dec 17, 2009 |
| Completion | Dec 17, 2009 |
| First posted | Jan 24, 2003 |
| Last update posted | Sep 3, 2024 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: